ObsEva (NASDAQ: OBSV)
ObsEva Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ObsEva Company Info
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.
News & Analysis
Valuation
Earnings Transcripts
ObsEva SA (OBSV) Q4 2019 Earnings Call Transcript
OBSV earnings call for the period ending December 31, 2019.
ObsEva SA (OBSV) Q3 2019 Earnings Call Transcript
OBSV earnings call for the period ending September 30, 2019.
ObsEva SA (OBSV) Q2 2019 Earnings Call Transcript
OBSV earnings call for the period ending June 30, 2019.
ObsEva SA (OBSV) Q1 2019 Earnings Call Transcript
OBSV earnings call for the period ending March 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.